Clinicians Becoming Reluctant To Recommend HPV Vaccine

The Centers for Disease Control (CDC), recommends the HPV vaccination for the prevention of Human Papillomavirus, an infection said to be responsible for cervical cancer. However, clinicians are beginning to recommend the vaccination less often to patients and parents alike.

In a recent study, the most commonly cited reasons given by parents for not vaccinating their children was their lack of knowledge and their belief that the vaccine was unnecessary.

…..22.8% of parents with adolescent boys and 13% of parents with adolescent girls said that the lack of recommendation from their clinician was the main reason for no HPV vaccination.’

According to The President’s Cancer Panel, only 54% of girls between the ages thirteen and seventeen, received the HPV vaccination in 2012 and the number is even lower for boys, at 21%. The panel discovered that less than 33% of girls and 7% of boys fulfilled all three vaccine recommendations, far less than the government’s goal of having 80% of adolescents HPV vaccinated.

With the overwhelming amount of recent research refuting the beneficial claims of HPV vaccines, clinicians may be taking a step back due to the lack of information about long-term side effects.

According to one article, there is clinical evidence that the probability of having a serious adverse reaction from the HPV vaccination may exceed the likelihood of getting cancer due to presence of the HPV virus.

Many researchers funded by Children’s Medical Safety Research Institute, have found numerous cases of adverse reactions to various vaccines including the HPV vaccine because manufacturers continue to use aluminum as an ingredient.

Although, many in the medical community continue to argue that vaccination benefits outweigh the risks of adverse reactions, they cannot disprove research completed on the topic.

While the CDC and the FDA continue to promote vaccines and attempt to push clinicians to recommend them, the knowledge and information regarding negative effects will increase.


Read More

Supporting Ground Breaking Research Achieves Results

The mission of the Dwoskin Family Foundation has always been focused on children’s health, scientific research and raising awareness of adverse reactions to vaccines. The foundation was co-founded by Claire Dwoskin, a child health activist, sponsor and trailblazer of a global  effort to address the increasing occurrence of  chronic illness and disability, including autoimmunity and age related neurological diseases.

Dwoskin is the founder of Children’s Medical Safety Research Institute (CMSRI) which provides funding for medical and scientific research  on vaccines and their ingredients. Some of the projects the institute has worked on involves the use of aluminum in vaccines. Aluminum is an experimentally demonstrated neurotoxin commonly used in vaccines and it is supposed to act as an exciting agent within the immune system.

The research points out that despite 90 years of widespread use of aluminum adjuvants, the agencies responsible for evaluating the safety of vaccines and their ingredients have not yet developed an adequate understanding about their mechanisms of action.  A significant issue is in the safety of an ingredient that medical science has limited knowledge of, and which  has shown surprisingly dangerous effects on health and ability. This research points out the harm in administering substances to children and adults without utilizing sufficiently rigorous research methods to support the safety of their inclusion in not one, but multiple vaccines administered throughout childhood. Current study designs do not assess vaccines or their ingredients for their cumulative or synergistic biological or genetic effects, or their reactivity with other substances humans are exposed to, such as glyphosate, a chemical in Roundup.

Specifically, aluminum vaccine adjuvants carry risks for autoimmunity, chronic brain inflammation and related neurological complications which may have profound and widespread negative health consequences. The research was conducted by  researchers, Dr. Lucija Tomljenovic,  and Dr. Christopher Shaw, a neuroscientist who are from the University of British Columbia in Canada. Dr. Shaw also serves as chair of the scientific advisory board at CMSRI.

In a previous study completed by Dr. Shaw, aluminum hydroxide injections were linked to motor deficits and motor neuron degeneration. This research was conducted originally to study the effects of aluminum adjuvants in anthrax and other vaccines which were used during the time of the Gulf War. Many veterans suffered from the multi-system disorder called Gulf War Syndrome (GWS). Those affected by GWS showed signs of neurological deficits including various cognitive dysfunctions and motor neuron disease.

The most likely culprit appeared to be aluminum hydroxide per the study’s conclusions, When the aluminum adjuvant was injected into mice, it resulted in motor neuron loss, motor weakness, cognitive impairments and impaired social and emotional behaviors. The mice displayed  comparable neurological deficits, cognitive dysfunctions and motor neuron disease from the same age and weight adjusted doses of aluminum hydroxide that were administered to GWS victims.

The research funded by the Dwoskin Family Foundation and now CMSRI can study vaccines for their potential causal relationships to chronic health problems that are  appearing  with increased frequency after exposure to vaccines and their toxic ingredients. Studying the effects helps  raise awareness and spread information about the harmful and adverse effects aluminum adjuvants and vaccines in general can have on the body.

Read More

CMSRI Funded Researchers Hosted in France

The Dwoskin Family Foundation has been pursuing autoimmune disease research in the area of vaccine safety and advocacy. The efforts to draw international attention and raise awareness to increasing incidences of chronic illnesses and disabilities relating to vaccine injections has been a main priority to the foundation.

In support of such research that provides new information focused around childhood health conditions, the Children’s Medical Safety Research Institute (CMSRI) offers funding to methodologically sound controlled scientific research on vaccines and their ingredients.

Four CMSRI funded researchers were called upon to present at a debate in Paris, France to discuss the lack of safety of vaccines and ingredients. The hearing and press conference is the first time a western governmental authority has called experts to testify about the adverse reactions to vaccines. The vaccine debate was presented in front of French Parliament, French Senate, health authorities, medical professionals and the public.

French government officials had many stakeholders involved at the conference that were for both sides of the debate to keep the discussions fair. There were a number of people who spoke about their adverse events after they were vaccinated; a panel of scientists and medical professionals also were in attendance to present their research regarding unsafe vaccines and ingredients as well as supporters of vaccines.

Four separate round table discussions occurred that were followed by open debates and public questioning. CMSRI funded researchers from around the globe presented various issues to the discussion board.

Professor Romain Gherardi was a part of the first round table and discussed the Bio-persistence and neuro-migration of aluminum adjuvant which is a key ingredient in vaccines. Gherardi, manager of the Center of Muscle Neuropathology at H. Mondor Hospital in France, was able to represent how far our funded research can travel.

Professor Yehuda Shoenfeld joined the first round table and shared findings of the autoimmune and inflammatory syndrome induced by adjuvants. Shoenfeld is the Director of the Center for Autoimmune Diseases at the Sheba Medical Center and Chairman of the 9th International Congress on Autoimmunity in Israel.

Professor Chris Exley, of Keele University in the United Kingdom, presented the toxicity of aluminum in humans in the first round table. During the second round table, Dr. Lucija Tomljenovic, of University of British Columbia located in Canada, went over vaccination against HPV and described the benefit and risk balance.

This was the first open discussion regarding the safety risks by vaccination possibly paving the way for other countries around the world to take a second look. CMSRI continues to discover new elements regarding adverse health conditions and raising awareness to broaden its reach.

Read More